Angiogenin functionally interacts with p53 and regulates p53-mediated apoptosis and cell survival

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• Angiogenin is a growth factor upregulated in cancers, potentially inhibiting apoptosis.
• Previous studies suggest angiogenin's role in cancer cell survival and progression.
• The precise mechanism of angiogenin's involvement in apoptosis regulation remains unclear.

Purpose of the Study:

• To elucidate the mechanism by which angiogenin regulates cell survival and apoptosis in cancer.
• To investigate the interaction between angiogenin and the tumor suppressor protein p53.
• To determine the functional significance of this interaction in cancer cell fate.

Main Methods:

• Co-immunoprecipitation and nuclear colocalization studies to assess angiogenin-p53 interaction.
• Gene silencing techniques to evaluate the impact of angiogenin on p53 pathway.
• Analysis of apoptosis-related gene expression (p53, p21, Bax, Bcl-2).
• Western blotting to detect p53 phosphorylation and ubiquitination.

Main Results:

• Angiogenin interacts with and colocalizes with p53 in the nucleus.
• Silencing angiogenin activates the p53 pathway, inducing apoptosis and downregulating Bcl-2.
• Angiogenin expression inhibits p53 phosphorylation and promotes its degradation via Mdm2, enhancing cell survival.
• Angiogenin directly interferes with p53 function, promoting anti-apoptotic effects.

Conclusions:

• Angiogenin promotes cancer cell survival and anti-apoptosis by inhibiting p53 function.
• This study reveals a novel interaction between angiogenin and p53 in regulating cell fate.
• Targeting angiogenin represents a potential therapeutic strategy for various cancers.